Drug/Small Molecule:
diethylstilbestrol

2D structure

Overview

Generic Names: DEB; DES; Diethylstilbesterol; Diethylstilbestrol BP; Diethylstilboesterol; Dietilestilbestrol; Percutatrine oestrogenique iscovesco; Rcra waste number U089; trans-Diethylstilbesterol; trans-Diethylstilbestrol; trans-Diethylstilboesterol
Trade Names: Acnestrol; Agostilben; Antigestil; Bio-des; Bufon; Climaterine; Comestrol; Comestrol estrobene; Cyren; Cyren A; Dawe's destrol; Desma; Destrol; Di-Estryl; DiBestrol 2 Premix; Diastyl; Dibestrol; Dicorvin; Distilbene; Domestrol; Dyestrol; Estilben; Estilbin MCO; Estril; Estrobene; Estrogenine; Estromenin; Estrosyn; Follidiene; Fonatol; Grafestrol; Gynopharm; Hi-Bestrol; Idroestril; Iscovesco; Makarol; Menostilbeen; Micrest; Microest; Milestrol; Neo-Oestranol I; New-Estranol 1; OeKolp; Oestrogenine; Oestrol vetag; Oestromenin; Oestromensil; Oestromensyl; Oestromienin; Oestromon; Pabestrol; Palestrol; Protectona; Rumestrol 1; Rumestrol 2; Sedestran; Serral; Sexocretin; Sibol; Sintestrol; Stibilium; Stil; Stil-Rol; Stilbestroform; Stilbestrol; Stilbestrone; Stilbetin; Stilboefral; Stilboestroform; Stilboestrol; Stilbofolin; Stilbofollin; Stilbol; Stilkap; Stilphostrol; Synestrin; Synthestrin; Synthoestrin; Synthofolin; Syntofolin; Tampovagan stilboestrol; Tylosterone; Vagestrol; neo-Oestranol 1; strobene
PharmGKB Accession Id: PA449307

Description

A synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders. It was also used formerly as a growth promoter in animals. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), diethylstilbestrol has been listed as a known carcinogen. (Merck, 11th ed) (source: Drug Bank)

Indication

Used in the treatment of prostate cancer. Previously used in the prevention of miscarriage or premature delivery in pregnant women prone to miscarriage or premature delivery. (source: Drug Bank)

ATC Therapeutic Categories

  • G03CB:Synthetic estrogens, plain
  • G03CC:Estrogens, combinations with other drugs
  • L02AA:Estrogens

Pharmacology, Interactions, and Contraindications

Mechanism Of Action

Estrogens diffuse into their target cells and interact with a protein receptor. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary. The combination of an estrogen with a progestin suppresses the hypothalamic-pituitary system, decreasing the secretion of gonadotropin-releasing hormone (GnRH). (source: Drug Bank)

Pharmacology

Diethylstilbestrol is a synthetic estrogen that was developed to supplement a woman's natural estrogen production. In 1971, the Food and Drug Administration (FDA) issued a Drug Bulletin advising physicians to stop prescribing DES to pregnant women because it was linked to a rare vaginal cancer in female offspring. (source: Drug Bank)

Absorption, Distribution, Metabolism, Elimination & Toxicity

Biotransformation

Hepatic. (source: Drug Bank)

Toxicity

Symptoms of overdose include nausea and vomiting, and withdrawal bleeding may occur in females. (source: Drug Bank)

Isomeric SMILES Code:

CC/C(=C(/CC)\c1ccc(cc1)O)/c2ccc(cc2)O (source: Drug Bank)

The following genes are in curated knowledge about this drug.

  Gene Relationship Evidence
Phenotype data available Genotype Data Available Literature annotations available Has annotations
NR1I2
  •   
  •   
  •   
  • FA
  •   
Publications

A list of non-curated publications that mention this drug along with other genes is available.

Drug Targets

Gene Description
ESR1 Uncurated Annotation (source: Drug Bank)
ESRRG Uncurated Annotation (source: Drug Bank)
TTR Uncurated Annotation (source: Drug Bank)

A list of non-curated publications that mention this drug along with other drugs is available.

Drug Interactions

Drug Description
amobarbital Uncurated Annotation The enzyme inducer decreases the effect of hormones (source: Drug Bank)
butalbital Uncurated Annotation The enzyme inducer decreases the effect of hormones (source: Drug Bank)
griseofulvin Uncurated Annotation The enzyme inducer decreases the effect of hormones (source: Drug Bank)
hexobarbital Uncurated Annotation The enzyme inducer decreases the effect of hormones (source: Drug Bank)
mephenytoin Uncurated Annotation The enzyme inducer decreases the effect of hormones (source: Drug Bank)
methylphenobarbital Uncurated Annotation The enzyme inducer decreases the effect of hormones (source: Drug Bank)
pentobarbital Uncurated Annotation The enzyme inducer decreases the effect of hormones (source: Drug Bank)
phenobarbital Uncurated Annotation The enzyme inducer decreases the effect of hormones (source: Drug Bank)
phenytoin Uncurated Annotation The enzyme inducer decreases the effect of hormones (source: Drug Bank)
prednisolone Uncurated Annotation The estrogenic agent increases the effect of corticosteroid (source: Drug Bank)
prednisone Uncurated Annotation The estrogenic agent increases the effect of corticosteroid (source: Drug Bank)
primidone Uncurated Annotation The enzyme inducer decreases the effect of hormones (source: Drug Bank)
raloxifene Uncurated Annotation Association not recommended (source: Drug Bank)
ursodeoxycholic acid Uncurated Annotation Estrogens decreases the effect of ursodiol (source: Drug Bank)

Non-Curated Information

A list of non-curated publications that mention this drug along with other diseases is available.

Additional Datasets

These datasets are minimally curated and are sorted alphabetically by title.

  1. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease

LinkOuts

Web Resource:
Wikipedia
DrugBank:
DB00255
ChEBI ID:
4531
KEGG Compound ID:
C07620
KEGG Drug ID:
D00577
PubChem Compound ID:
3054
PubChem Substance ID:
9822

Common Searches

Search PubMed
Search Medline Plus
Search PubChem
Search CTD

Non-Curated Publications

A list of non-curated publications that mention this drug is available.

PharmGKB integrates drug information from different sources: DrugBank, Open Eye Scientific Software.
Add New Alternate Name
Add New ATC Term
Add Cross Reference
Add a metabolite
Add a text annotation
Add a drug target
hint: enter a gene
    Add a drug interaction
    hint: enter a drug
    PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (GM61374).
    ©2001-2010 PharmGKB.